ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/01/25 | 1,348 | 1,364 | 1,234 | 1,246 | -102 | -7.6% | 1,548,300 |
| 2022/01/24 | 1,366 | 1,369 | 1,326 | 1,348 | -48 | -3.4% | 762,100 |
| 2022/01/21 | 1,457 | 1,462 | 1,378 | 1,396 | -58 | -4% | 697,900 |
| 2022/01/20 | 1,401 | 1,455 | 1,398 | 1,454 | +44 | +3.1% | 538,500 |
| 2022/01/19 | 1,379 | 1,422 | 1,378 | 1,410 | +6 | +0.4% | 474,100 |
| 2022/01/18 | 1,411 | 1,446 | 1,394 | 1,404 | +25 | +1.8% | 614,500 |
| 2022/01/17 | 1,400 | 1,414 | 1,376 | 1,379 | -23 | -1.6% | 292,900 |
| 2022/01/14 | 1,381 | 1,405 | 1,347 | 1,402 | +7 | +0.5% | 604,100 |
| 2022/01/13 | 1,405 | 1,428 | 1,395 | 1,395 | -25 | -1.8% | 391,000 |
| 2022/01/12 | 1,425 | 1,453 | 1,405 | 1,420 | -28 | -1.9% | 560,500 |
| 2022/01/11 | 1,380 | 1,452 | 1,365 | 1,448 | +73 | +5.3% | 628,800 |
| 2022/01/07 | 1,387 | 1,388 | 1,339 | 1,375 | +4 | +0.3% | 514,500 |
| 2022/01/06 | 1,400 | 1,423 | 1,359 | 1,371 | -59 | -4.1% | 629,800 |
| 2022/01/05 | 1,450 | 1,451 | 1,416 | 1,430 | -42 | -2.9% | 489,400 |
| 2022/01/04 | 1,500 | 1,501 | 1,443 | 1,472 | -9 | -0.6% | 422,600 |
| 2021/12/30 | 1,454 | 1,494 | 1,446 | 1,481 | +8 | +0.5% | 388,300 |
| 2021/12/29 | 1,385 | 1,488 | 1,385 | 1,473 | +91 | +6.6% | 906,200 |
| 2021/12/28 | 1,392 | 1,403 | 1,360 | 1,382 | -3 | -0.2% | 875,500 |
| 2021/12/27 | 1,418 | 1,418 | 1,372 | 1,385 | -39 | -2.7% | 570,600 |
| 2021/12/24 | 1,439 | 1,445 | 1,410 | 1,424 | +7 | +0.5% | 383,000 |
| 2021/12/23 | 1,392 | 1,424 | 1,387 | 1,417 | +16 | +1.1% | 441,700 |
| 2021/12/22 | 1,367 | 1,407 | 1,349 | 1,401 | +53 | +3.9% | 677,400 |
| 2021/12/21 | 1,330 | 1,359 | 1,307 | 1,348 | +42 | +3.2% | 531,000 |
| 2021/12/20 | 1,310 | 1,338 | 1,303 | 1,306 | -11 | -0.8% | 494,100 |
| 2021/12/17 | 1,331 | 1,351 | 1,307 | 1,317 | -24 | -1.8% | 587,800 |
| 2021/12/16 | 1,376 | 1,383 | 1,339 | 1,341 | -8 | -0.6% | 372,100 |
| 2021/12/15 | 1,335 | 1,359 | 1,331 | 1,349 | +4 | +0.3% | 306,500 |
| 2021/12/14 | 1,376 | 1,387 | 1,337 | 1,345 | -36 | -2.6% | 480,900 |
| 2021/12/13 | 1,428 | 1,429 | 1,376 | 1,381 | -25 | -1.8% | 329,900 |
| 2021/12/10 | 1,431 | 1,442 | 1,403 | 1,406 | -37 | -2.6% | 308,400 |
| 2021/12/09 | 1,460 | 1,484 | 1,440 | 1,443 | -12 | -0.8% | 382,000 |
| 2021/12/08 | 1,447 | 1,466 | 1,433 | 1,455 | +27 | +1.9% | 412,500 |
| 2021/12/07 | 1,399 | 1,430 | 1,378 | 1,428 | +55 | +4% | 576,000 |
| 2021/12/06 | 1,400 | 1,413 | 1,350 | 1,373 | -47 | -3.3% | 670,700 |
| 2021/12/03 | 1,401 | 1,423 | 1,358 | 1,420 | +36 | +2.6% | 660,300 |
| 2021/12/02 | 1,459 | 1,481 | 1,379 | 1,384 | -97 | -6.5% | 1,115,100 |
| 2021/12/01 | 1,500 | 1,507 | 1,452 | 1,481 | ±0 | ±0% | 467,800 |
| 2021/11/30 | 1,485 | 1,526 | 1,474 | 1,481 | +27 | +1.9% | 637,200 |
| 2021/11/29 | 1,483 | 1,527 | 1,449 | 1,454 | -72 | -4.7% | 773,600 |
| 2021/11/26 | 1,545 | 1,568 | 1,505 | 1,526 | -33 | -2.1% | 388,800 |
| 2021/11/25 | 1,570 | 1,591 | 1,518 | 1,559 | -26 | -1.6% | 503,800 |
| 2021/11/24 | 1,541 | 1,592 | 1,532 | 1,585 | +60 | +3.9% | 722,600 |
| 2021/11/22 | 1,477 | 1,526 | 1,470 | 1,525 | +55 | +3.7% | 639,300 |
| 2021/11/19 | 1,500 | 1,527 | 1,456 | 1,470 | -32 | -2.1% | 1,028,600 |
| 2021/11/18 | 1,559 | 1,560 | 1,493 | 1,502 | -46 | -3% | 931,300 |
| 2021/11/17 | 1,650 | 1,650 | 1,539 | 1,548 | -91 | -5.6% | 1,032,900 |
| 2021/11/16 | 1,648 | 1,673 | 1,602 | 1,639 | -13 | -0.8% | 830,100 |
| 2021/11/15 | 1,635 | 1,660 | 1,591 | 1,652 | +35 | +2.2% | 656,300 |
| 2021/11/12 | 1,554 | 1,619 | 1,547 | 1,617 | +73 | +4.7% | 439,700 |
| 2021/11/11 | 1,536 | 1,552 | 1,525 | 1,544 | +8 | +0.5% | 280,000 |
801～
850
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 241,500円 | +21.7% | +999.9% | 0.00% | 10.06倍 | 3.33倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 東和薬品 | 263,700円 | +15.0% | -7.3% | 2.65% | 8.65倍 | 0.82倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 234,300円 | +14.2% | +41.0% | 1.96% | 11.48倍 | 1.17倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 持田薬 | 309,000円 | +3.0% | +27.5% | 2.59% | 19.56倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 148,600円 | +8.8% | +99.9% | 3.50% | 9.49倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
